<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02890979</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00015499</org_study_id>
    <secondary_id>NCI-2016-01318</secondary_id>
    <secondary_id>STUDY00015499</secondary_id>
    <nct_id>NCT02890979</nct_id>
  </id_info>
  <brief_title>Swallowable Sponge Cell Sampling Device and Next Generation Sequencing in Detecting Esophageal Cancer in Patients With Low or High Grade Dysplasia, Barrett Esophagus, or Gastroesophageal Reflux Disease</brief_title>
  <official_title>Next Generation Sequencing of Esophageal Cytology for the Early Detection of Esophageal Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>OHSU Knight Cancer Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Oregon Health and Science University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>OHSU Knight Cancer Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This pilot clinical trial studies how well a swallowable sponge cell sampling device and next&#xD;
      generation sequencing work in detecting esophageal cancer in patients with low or high grade&#xD;
      dysplasia, Barrett esophagus, or gastroesophageal reflux disease. Checking biomarkers in&#xD;
      abnormal esophageal cells using a swallowable sponge cell sampling device and next generation&#xD;
      sequencing may improve diagnosis and treatment of esophageal cancer.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVES:&#xD;
&#xD;
      I. Determine the sensitivity and specificity of next generation sequencing for the detection&#xD;
      of esophageal cancer from esophageal sponge cytology specimens.&#xD;
&#xD;
      SECONDARY OBJECTIVES:&#xD;
&#xD;
      I. Determine the ability of next generation gene sequencing (NGS) of esophageal sponge&#xD;
      samples to collect an adequate sample to detect mutations that are present in the underlying&#xD;
      tissue.&#xD;
&#xD;
      II. Determine the cost associated with esophageal cytology with next generation genome&#xD;
      sequencing as a screening tool.&#xD;
&#xD;
      III. Continue to collect safety and tolerability data related to the use of the Oesotest&#xD;
      esophageal sponge.&#xD;
&#xD;
      IV. Determine the limitations of esophageal sponge cytology and future needs to improve this&#xD;
      technique.&#xD;
&#xD;
      V. Use the data collected to design a larger screening trial to determine the ability of&#xD;
      esophageal cytology with next generation sequencing to screen for esophageal cancer in the&#xD;
      general population.&#xD;
&#xD;
      OUTLINE:&#xD;
&#xD;
      Patients undergo cytology specimen collection procedure using a swallowable sponge cell&#xD;
      sampling device.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 3, 2016</start_date>
  <completion_date type="Actual">October 10, 2017</completion_date>
  <primary_completion_date type="Actual">October 10, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Device Feasibility</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Detection of gene mutations using next generation sequencing (NGS)</measure>
    <time_frame>Up to 2 years</time_frame>
    <description>Will calculate the concordance of the gene mutations identified from the sponge sample to those identified from the tissue biopsy (control).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sensitivity and specificity of the NGS probes to detect underlying esophageal dysplasia or cancer</measure>
    <time_frame>Up to 2 years</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">11</enrollment>
  <condition>Barrett Esophagus</condition>
  <condition>Dysplasia</condition>
  <condition>Esophageal Adenocarcinoma</condition>
  <condition>Esophageal Squamous Cell Carcinoma</condition>
  <condition>Gastroesophageal Reflux Disease</condition>
  <condition>Metaplasia</condition>
  <arm_group>
    <arm_group_label>Screening (cytology collection)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients undergo cytology specimen collection procedure using a swallowable sponge cell sampling device.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cytology Specimen Collection Procedure</intervention_name>
    <description>Undergo cytology specimen collection procedure using a swallowable sponge cell sampling device</description>
    <arm_group_label>Screening (cytology collection)</arm_group_label>
    <other_name>Cytologic Sampling</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Laboratory Biomarker Analysis</intervention_name>
    <description>Correlative studies</description>
    <arm_group_label>Screening (cytology collection)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Quality-of-Life Assessment</intervention_name>
    <description>Ancillary studies</description>
    <arm_group_label>Screening (cytology collection)</arm_group_label>
    <other_name>Quality of Life Assessment</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Swallowable Sponge Cell Sampling Device</intervention_name>
    <description>Undergo cytology specimen collection procedure using a swallowable sponge cell sampling device</description>
    <arm_group_label>Screening (cytology collection)</arm_group_label>
    <other_name>Swallowable Sponge</other_name>
    <other_name>Swallowable Sponge Device</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Ability to understand and the willingness to sign a written informed consent document&#xD;
&#xD;
          -  Patients must be scheduled for a procedure capable of providing a definitive&#xD;
             pathologic diagnosis and evaluating for complications of the esophageal sponge on the&#xD;
             same day as the study procedure, either upper endoscopy or surgical esophagectomy&#xD;
&#xD;
          -  One of the following inclusion criteria must be true for patient to be eligible for&#xD;
             enrollment:&#xD;
&#xD;
          -  Subjects with known esophageal cancer (adenocarcinoma or squamous cell carcinoma)&#xD;
&#xD;
          -  Subjects with a history of low or high grade dysplasia&#xD;
&#xD;
          -  Subjects with risk factors for esophageal malignancy including Barrett?s esophagus and&#xD;
             gastroesophageal reflux disease (GERD)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subjects that are unable to swallow a tablet/pill&#xD;
&#xD;
          -  Subjects with completely obstructing esophageal cancer&#xD;
&#xD;
          -  Subjects with known or suspected esophageal varices&#xD;
&#xD;
          -  Uncontrolled intercurrent illness including, but not limited to, ongoing or active&#xD;
             infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac&#xD;
             arrhythmia, or psychiatric illness/social situations that would limit compliance with&#xD;
             study requirements&#xD;
&#xD;
          -  Any condition which, in the opinion of the investigator precludes the patient from&#xD;
             completion of the study procedure&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James Dolan</last_name>
    <role>Principal Investigator</role>
    <affiliation>OHSU Knight Cancer Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>OHSU Knight Cancer Institute</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>September 1, 2016</study_first_submitted>
  <study_first_submitted_qc>September 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 7, 2016</study_first_posted>
  <last_update_submitted>November 23, 2020</last_update_submitted>
  <last_update_submitted_qc>November 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Esophageal Neoplasms</mesh_term>
    <mesh_term>Esophageal Squamous Cell Carcinoma</mesh_term>
    <mesh_term>Barrett Esophagus</mesh_term>
    <mesh_term>Gastroesophageal Reflux</mesh_term>
    <mesh_term>Esophagitis, Peptic</mesh_term>
    <mesh_term>Metaplasia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

